Axinn Represents Berkshire Partners in the Antitrust Aspects of its Acquisition of Forcura and Medalogix
March 19, 2025
Axinn successfully represented Berkshire Partners in the antitrust aspects of the parallel acquisitions of two post-acute care software companies: Forcura, an intelligent workflow management company; and Medalogix, a clinical decision support company. Together, the two complementary companies create a leading healthcare technology platform that brings real efficiencies and improved patient care, starting with home-based healthcare and expanding across the broader healthcare industry. Berkshire is the majority owner of the combined company.
The team was led by partners John Harkrider and Craig Minerva along with associates Laviana Alharmoosh, Josh Jowdy, and Megan Dill. The deal closed on March 19, 2025.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
National Bar Association 100th Annual Convention and Exhibits
Sponsorship
Antitrust
Keeping Pace: Updates in Cartel Enforcement
Webinar
Antitrust
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
Navigating the Hart-Scott-Rodino Act in 2025
Webinar
Antitrust
AHLA Annual Meeting 2025
Speaking Engagement
Antitrust
State by State, Pre-Merger Notifications Expand
Axinn Viewpoints
Antitrust
FTC claims diverging market from EU in Mars/Kellanova clearance
Media Mentions
Keeping an Eye on the Ball: America First Antitrust Weighs in on the “Uniquely American System of Scholar Athletics”
Axinn Viewpoints
Antitrust
Wait, We Have To Tell Who? What You Need To Know About State Premerger Notifications
Podcast
MBK | MSK Fellowship Summit 2025
Sponsorship
Antitrust